...
首页> 外文期刊>European urology >The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review
【24h】

The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review

机译:在先前治疗泌尿外癌症后接受肾移植术后肾移植患者的肿瘤复发风险:系统审查

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Renal transplantation is the gold standard renal replacement therapy in end-stage renal disease owing to its superior survival and quality of life compared with dialysis. When the potential recipient has a history of cancer, the waiting period before renal transplantation is usually based on the Cincinnati Registry.
机译:背景:肾移植是由于其与透析相比的卓越生存和生活质量较高的生存和生活质量,是肾脏移植的末期肾脏蛋白替代疗法。 当潜在受体有癌症史时,肾移植前的等待时间通常基于辛辛那提登记处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号